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Bartonella quintana, the agent of trench fever and a cause of endocarditis and bacillary angiomatosis in
humans, has the highest reported in vitro hemin requirement for any bacterium. We determined that eight
membrane-associated proteins from B. quintana bind hemin and that a ;25-kDa protein (HbpA) was the
dominant hemin-binding protein. Like many outer membrane proteins, HbpA partitions to the detergent phase
of a Triton X-114 extract of the cell and is heat modifiable, displaying an apparent molecular mass shift from
approximately 25 to 30 kDa when solubilized at 100°C. Immunoblots of purified outer and inner membranes
and immunoelectron microscopy with whole cells show that HbpA is strictly located in the outer membrane and
surface exposed, respectively. The N-terminal sequence of mature HbpA was determined and used to clone the
HbpA-encoding gene (hbpA) from a lambda genomic library. The hbpA gene is 816 bp in length, encoding a
predicted immature protein of approximately 29.3 kDa and a mature protein of 27.1 kDa. A Fur box homolog
with 53% identity to the Escherichia coli Fur consensus is located upstream of hbpA and may be involved in
regulating expression. BLAST searches indicate that the closest homologs to HbpA include the Bartonella
henselae phage-associated membrane protein, Pap31 (58.4% identity), and the OMP31 porin from Brucella
melitensis (31.7% identity). High-stringency Southern blots indicate that all five pathogenic Bartonella spp.
possess hbpA homologs. Recombinant HbpA can bind hemin in vitro; however, it does not confer a hemin-
binding phenotype upon E. coli. Intact B. quintana treated with purified anti-HbpA Fab fragments show a
significant (P < 0.004) dose-dependent decrease in hemin binding relative to controls, suggesting that HbpA
plays an active role in hemin acquisition and therefore pathogenesis. HbpA is the first potential virulence
determinant characterized from B. quintana.
Trench fever is an arthropod-borne disease caused by Bar-
tonella quintana and occurs about 10 days following the bite of
an infected body louse (Pediculus humanus) (14). The morbid-
ity impact of trench fever was second only to influenza in terms
of lost man-hours during World War I, and thousands of
troops were debilitated by the disease (56). Following a period
of quiescence, trench fever reappeared during World War II
(32) and appeared sporadically for the next four decades. Al-
though the symptoms of trench fever can vary, the disease
usually presents with mild to moderately severe fever, chills,
malaise, myalgia, and bone pain that is prominent in the tibia
(hence the nickname “shinbone fever”) (65). Occasionally, pa-
tients develop splenomegaly and a maculopapular rash resem-
bling the rose spots of typhoid fever (56). Trench fever gener-
ally lasts about 1 week, but some cases can persist for up to 12
weeks with recurrent febrile episodes and protracted bactere-
mia (59).
B. quintana is currently reemerging as an etiologic agent
primarily afflicting homeless, alcoholic males that live within
the inner cities of the United States and Europe (28). Al-
though many cases of “urban trench fever” present with symp-
toms of the classical disease (27), the pathogen can also cause
potentially fatal bacillary angiomatosis (31), endocarditis (53),
lymphadenopathy (31), infections of the central nervous sys-
tem (45), and lytic bone lesions (30, 31). In addition, B. quin-
tana infections have been reported in both immunocompro-
mised individuals as well as in immunocompetent patients
(54). However, in spite of B. quintana’s emerging status, little
is known about the pathogen’s current reservoir and vector of
transmission, although exposure to lice appears to correlate
with incidence of disease (30).
To date, no virulence determinant has been characterized
from B. quintana. Pili (6) and specialized extensions of the
outer membrane (13) are thought to serve as host cell ad-
hesins. Recent work has shown that B. quintana binds to mem-
brane ruffles and can subsequently invade cultured vascular
endothelial cells within 1 minute of coincubation. Tissue biop-
sies from endocarditis vegetations were also found to contain
intracellular B. quintana (13). Internalized bacteria divide and
form vacuoles that resemble morulae observed during ehrli-
chiosis. The morulae contain numerous bacteria and blebs,
suggesting that membranes are sloughed as the pathogen
grows. Blebs are apparently more common in infected, cul-
tured host cells than in endocarditis tissues (13).
Bartonella species are the only bacterial pathogens for hu-
mans that engage in the practice of hemotrophy, i.e., erythro-
cyte parasitism. Because of this unusual parasitic strategy all
Bartonella species require erythrocytes or hemin supplements
in order to grow in vitro. In fact, B. quintana has the greatest
known hemin requirement (20 to 40 mg/ml of medium) for a
bacterium (41). This study was undertaken to elucidate the
molecular mechanism whereby hemin is acquired by B. quin-
tana in order to better understand the reasons for this patho-
gen’s extraordinary hemin requirement.
MATERIALS AND METHODS
Bacterial strains and culture conditions. E. coli was grown overnight at 37°C
in Luria-Bertani (LB) medium using standard antibiotic supplements when re-
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quired. Bartonella cultures were grown on heart infusion agar supplemented with
4% sheep erythrocytes and 2% sheep serum. With the exception of B. bacillifor-
mis, Bartonella cultures were incubated at 37°C in 5% CO2 and 100% relative
humidity and were harvested at 3 days postinoculation (approximately mid-log
phase [69]). B. bacilliformis cultures were grown and harvested as before (7). For
gene expression in E. coli, cells were grown to mid-log phase in LB medium
containing appropriate antibiotics, treated with IPTG (isopropyl-b-D-thiogalac-
topyranoside; 5 mM, final concentration), and grown for an additional 2 h prior
to harvest. Bartonella and E. coli strains used or generated in this study are
summarized in Table 1.
Membrane fractionation and purification. Ten plates of B. quintana were
harvested into 1 ml of ice-cold Dulbecco phosphate-buffered saline (PBS; pH
7.4) and then homogenized for 3 min using 0.1-mm glass beads and a Mini
Beadbeater-8 (BioSpec products, Bartlesville, Okla.). The resulting lysate was
centrifuged for 5 s at 3,000 3 g, and the supernatant was retained. To obtain a
crude membrane preparation (CMP), the mixture was clarified twice by centri-
fuging for 15 min at 1,000 3 g (4°C) and then retaining the supernatant. To
obtain total membranes, CMP was centrifuged for 2 h at 100,000 3 g (4°C) in an
SW60 rotor (Beckman Instruments, Fullerton, Calif.), and the pellet was re-
tained. Outer and inner membranes were prepared by centrifuging CMP on a 35
to 55% sucrose step gradient for 40 h at 222,000 3 g in an SW41 rotor at 4°C
(Beckman). Tea-colored inner membranes were collected near the top of the
gradient, while fluffy white outer membranes were collected near the bottom of
the tube (44). Membranes were dialyzed overnight at 4°C against 10-fold diluted
PBS (pH 7.4) and then lyophilized, suspended in 0.5 ml sterile distilled water,
and stored at 220°C until needed. Triton X-114 extracts of whole-cell lysates
were prepared (9), followed by phase separation of the extract to obtain integral
membrane proteins (18).
SDS-PAGE and hemin-binding blots. Protein concentrations were determined
with a bicinchoninic acid protein kit (Sigma Chemical, St. Louis, Mo.). Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was done ac-
cording to the general methods of Laemmli (33). Approximately 20 mg of protein
were solubilized in Laemmli sample buffer (LSB) and separated by SDS-PAGE
(12.5% [wt/vol] acrylamide), and the resulting gel was fixed and stained with
Coomassie brilliant blue R (5). For hemin-binding blots, unfixed gels were
transferred to nitrocellulose by the general methods of Towbin et al. (63). The
resulting blots were rinsed with Tris-buffered saline (TBS; 10 mM Tris-HCl [pH
8.0] containing 150 mM NaCl) and Tween 20 (0.1% [vol/vol]) and subsequently
probed for 1.5 h with TBS containing hemin (10 mg/ml). Blots were subsequently
washed three times for 30 min with TBS-Tween 20 (0.1% [vol/vol]) and devel-
oped using enhanced chemiluminescence (ECL) reagents (Amersham Pharma-
cia, Piscataway, N.J.). Hemin-binding protein (HBP) bands were visualized by
exposing the blot to autoradiographic film (Labscientific, Livingston, N.J.).
Preparation of polyclonal antibody and Fab fragments. Precipitates from
Triton X-114 extracts of the B. quintana cell, as prepared above, were solubilized
in LSB and separated by SDS-PAGE. The resulting gel was briefly rinsed in
water and stained with Coomassie brilliant blue (0.05%). HbpA bands (ca. 100
mg total protein) were excised and used to generate rabbit anti-HbpA antiserum
as before (50). Immunoglobulin G (IgG) was purified from the antiserum using
an Nab chromatography kit (Pierce, Rockford, Ill.). Fab fragments were pre-
pared from IgG with an ImmunoPure Fab kit (Pierce).
N-terminal sequencing. Triton X-114 extracts of B. quintana were precipitated
with methanol-chloroform as described above, and the precipitate was solubi-
lized into LSB and separated by SDS-PAGE. The resulting gel was blotted to
polyvinylidene difluoride (37), and the excised HbpA band was subjected to
Edman degradation using an ABI 431A automated peptide sequencer. Sequenc-
ing was performed on two separate samples.
Immunoblots and immunoelectron microscopy. Immunoblots, immunogold
analysis and transmission electron microscopy were done as previously described
(50). Unless otherwise indicated, rabbit anti-HbpA antiserum was used at a
1:10,000 dilution.
Hemin binding and inhibition assays. Four plates of B. quintana were har-
vested into Tris-HCl buffer (0.1 M, pH 8.0) and centrifuged for 5 min at 4,620 3
g. The pellet was washed twice by resuspending it in 3 ml of Tris buffer and
recentrifuging it. The final pellet was resuspended in Tris buffer to a final optical
density at 600 nm of 1. For inhibition experiments, 1 ml of cells was preincubated
for 1 h at 24°C with 40 or 80 ml (0.2 or 0.4 mg/ml, respectively) of anti-HbpA Fab
fragments. Cells treated with equal volumes of PBS served as controls. Hemin
binding was subsequently measured using a standard liquid binding assay (20, 22,
26, 43) and a Spectronic Genesys 2 spectrophotometer (Milton Roy, Rochester,
N.Y.).
Preparation and manipulation of DNA. Plasmids used or generated in this
study are given in Table 1. Chromosomal DNA from Bartonella spp. was pre-
pared using a hexadecyltrimethyl ammonium bromide technique (5). Plasmids
were propagated in E. coli (DH5a or XLOLR) and isolated with a Perfectprep
plasmid kit (Eppendorf Scientific, Westbury, N.Y.) or a Qiagen Midi Prep kit
(Qiagen, Valencia, Calif.). When required, DNA fragments or amplicons were
purified from agarose gels using a GeneClean II kit (Bio 101, La Jolla, Calif.). A
genomic library of B. quintana was generated by partial digestion of B. quintana
chromosomal DNA with Sau3AI and ligation of the resulting fragments into
BamHI-cut lambda Zap Express arms according to the manufacturer’s instruc-
tions (Stratagene, La Jolla, Calif.). Ligations were done using standard proce-
dure (5), and transformations were performed by the methods of Chung et al.
(16). High-stringency DNA hybridizations (Southern blots and lambda library
screening) and PCR were conducted as previously described (7).
Nucleotide sequencing and analysis. Both DNA strands of hbpA were se-
quenced using a BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE
Applied Biosystems) and an automated DNA sequencer (ABI model 377). Se-
quence data were compiled and analyzed by PC/GENE 6.8 software (Intellige-
netics, Mountain View, Calif.). BLAST 2.0 (1) was used for database searches,
while sequence alignments were done using FASTA 2.0 (46), CLUSTAL W
1.6 (61), and BOXSHADE 3.21 (K. Hofmann, and M. D. Baron, http://www.ch
.embnet.org/software/BOX_form.html, 1998).
Statistical analysis. Statistical analyses (Student’s t test, standard error of the
mean [SEM]) and graphs were done using SigmaPlot 3.0 software (Jandel Sci-
entific, San Rafael, Calif.). A value of P , 0.05 was considered statistically
significant.
Nucleotide sequence accession number. The GenBank accession number for
the B. quintana hbpA sequence is AF266281.
RESULTS
Identification of B. quintana HBPs. Eight HBPs of 11, 12, 19,
25 or 30 (depending upon solubilization temperature), 29, 36,
42, and 87 kDa were identified on hemin blots containing total
cell lysates of B. quintana (Fig. 1A). HBPs with identical mo-
lecular masses were also observed in hemin blots of total mem-
branes purified from B. quintana (Fig. 1B). Of the eight HBPs,
a prominent HBP band of 25 kDa (termed HbpA) was ob-
served to shift from approximately 25 to 30 kDa when heated,
thus displaying a common characteristic of outer membrane
proteins (see Discussion). The HbpA band also demonstrated
the highest affinity for hemin relative to the seven other HBPs,
based upon its unique ability to retain bound hemin after a
24-h wash with TBS (data not shown). In addition, the HbpA
band was the only protein that was visibly brown on blots
probed with hemin, prior to ECL detection (data not shown).
Taken together, these data formed the basis of our hypothesis
that HbpA was an HBP located in the outer membrane of B.
quintana.
Anti-HbpA antibodies and localization of HbpA in the B.
quintana cell. To characterize HbpA, whole-cell lysates were
subjected to phase partitioning with Triton X-114. HbpA was
observed predominantly in the detergent phase, which is typ-
TABLE 1. Bacterial strains and plasmids used in this study
Strain or
plasmid Relevant characteristic(s)
Source or
reference
Strains
Bartonella spp.
B. bacilliformis KC583 Type strain 12
B. clarridgeiae Type strain 34
B. doshiae R18 Type strain 8
B. elizabethae Type strain 19
B. grahamii V2 Type strain 8
B. henselae Houston
R1302
Type strain 47
B. quintana OK 90-268 Human isolate CDCa
B. vinsonii Baker Vole agent 69
E. coli
DH5a Host strain for cloning Gibco-BRL
XL1-Blue MRF9 Host strain for l phage Stratagene
XLOLR Host strain for pBK-CMV and
its derivatives
Stratagene
Plasmids
pBK-CMV Excised vector from l Zap Stratagene
pHBP-CMV pBK-CMV plus 3.5-kbp
Sau3AI insert with hbpA
This study
a CDC, Centers for Disease Control and Prevention, Atlanta, Ga.
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ical of integral membrane proteins (9, 18). This phase was
found to contain two dominant proteins, HbpA and a 36-kDa
polypeptide, plus minor proteins of 33, 42, 46, and 87 kDa (Fig.
2A, lane 2). The Triton X-114 detergent fraction was further
separated by SDS-PAGE and HbpA bands were excised from
unfixed, Coomassie blue-stained gels to generate rabbit poly-
clonal antibody. Specificity of the anti-HbpA antibody for
HbpA was verified using immunoblots (Fig. 2B). The antibody
was able to recognize both the 25- and the 30-kDa forms of the
molecule (Fig. 2C).
To verify HbpA’s suspected outer membrane location in the
cell, inner and outer membranes were isolated from B. quin-
tana in a manner similar to that described for B. bacilliformis
(39) using sucrose density gradient centrifugation (44). The
average buoyant density values (r) were determined from
three membrane preparations and were calculated as 1.08 for
the inner membrane and 1.2 for the outer membrane. These
density values are very close to those reported for E. coli (42)
and Salmonella spp. (44). Likewise, the characteristic tea-color
of the B. quintana inner membrane, due to cytochromes, and
white floculence of the outer membrane was in keeping with
characteristics of the respective membranes from E. coli. The
protein profiles of the outer and inner membranes were dis-
tinct on SDS-PAGE (Fig. 3A). Immunoblot analysis using anti-
HbpA antiserum detected HbpA in the outer membrane but
not in the inner membrane (Fig. 3B). To corroborate these
data, immunogold analyses were done using anti-HbpA and
intact bacteria to determine if HbpA is surface exposed. The
data clearly show that HbpA is both exposed and abundant on
the surface of the B. quintana cell (Fig. 4). Immunogold con-
trols prepared with an equal volume of PBS or preimmune
rabbit serum showed insignificant protein A-gold binding (not
shown).
In vivo hemin binding by HbpA and inhibition with Fabs. A
standard liquid hemin-binding assay was done with freshly
harvested B. quintana. Untreated B. quintana cells bound ap-
proximately 22% of exogenous hemin (1.4 mg of hemin/mg of
FIG. 1. Identification of hemin-binding proteins of B. quintana using hemin
blots. (A) Total cell lysates. (B) Total membranes. Samples were solubilized in
LSB at 24 or 100°C as indicated and then separated by SDS-PAGE, transferred
to nitrocellulose, probed with hemin, and developed using ECL reagents (Am-
ersham Pharmacia) as described in Materials and Methods. The position of the
two forms of HbpA are indicated by asterisks. Molecular mass standards are
given to the left in kilodaltons.
FIG. 2. Monospecificity of the anti-HbpA antibody and reactivity against
both molecular mass forms of HbpA. (A) Coomassie blue-stained SDS-PAGE
gel containing a B. quintana cell lysate (lane 1) and a phase-separated Triton
X-114 cell extract of the bacterium (lane 2). Both samples were solubilized at
100°C in LSB. HbpA is arrowed. (B) Immunoblot corresponding to panel A but
developed with rabbit anti-HbpA antiserum showing monospecificity of the anti-
HbpA antibody. (C) Immunoblot showing anti-HbpA antibody reactivity to
phase-separated Triton X-114 cell extracts of B. quintana solubilized at 25°C
(lane 1) and 100°C (lane 2). Note that the antibody recognizes both molecular
mass forms of HbpA in panel C. Molecular mass standards are given to the left
in kilodaltons.
FIG. 3. Localization of HbpA in the outer membrane of B. quintana. Lanes:
1, cell lysate; 2, purified inner membrane; 3, outer membrane. (A) Coomassie
blue-stained SDS-PAGE gel. (B) Corresponding immunoblot developed with
anti-HbpA showing HbpA in the outer membrane (arrowed). All samples were
solubilized at 100°C in LSB. Molecular mass standards are given to the left in
kilodaltons.
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B. quintana protein) during a 60-min assay; this percentage
falls within the range of hemin binding exhibited by several
human bacterial pathogens (20, 26, 43, 51). B. quintana pre-
treated with anti-HbpA Fab fragments showed a very signifi-
cant (P , 0.004), dose-dependent decrease in hemin binding,
relative to controls treated with an equal volume of PBS. For
example, B. quintana treated with 0.2 mg of Fab per ml showed
a 26% decrease in hemin binding relative to its respective PBS
control, whereas B. quintana treated with 0.4 mg of Fab per ml
exhibited a 41% decrease in hemin binding relative to PBS
controls (Fig. 5). These data show a dose-dependent decrease
in hemin binding by B. quintana when cells are treated with
anti-HbpA Fabs prior to the liquid hemin-binding assay.
Cloning the hbpA gene. The N terminus of mature HbpA
was determined from two separate samples and was found to
be ADVIATHEAAPVITTPNF. BLASTp searches with this
amino acid sequence showed a high probability hit (63% iden-
tity) with the Pap31 protein from B. henselae (10). This discov-
ery prompted us to design PCR primers based upon the first 31
nucleotides and the last 25 nucleotides (inverse complement)
of the pap31 open reading frame (ORF) (GenBank accession
no. AF001274). The pap31 primers produced PCR products of
identical size (;840 bp) from both B. henselae and B. quintana
DNA templates (data not shown). The B. quintana amplicon
was subsequently used to screen a lambda ZAP Express (Strat-
agene) genomic library of B. quintana for hbpA. A set of pos-
itive plaques was identified, isolated, and tested by PCR to
determine if a full-length copy of hbpA was present. A positive
lambda clone that contained the full-length hbpA gene was
excised in vivo to produce pHBP-CMV. This plasmid contains
a Sau3AI insert of approximately 3.5 kbp.
Nucleotide sequence of hbpA. The sequence of hbpA was
determined from both strands of pHBP-CMV (Fig. 6). The B.
quintana hbpA gene is 816 bp long and has a 39.1 mol% G1C,
a level in close agreement with the 38.5 mol% G1C for the B.
quintana genome (64). The region upstream of the start codon
of hbpA contains a consensus promoter sequence (0.92 score
by prokaryotic promoter neural network prediction) and a
potential ribosome-binding site with perfect identity to the E.
coli consensus sequence, AGGA (23). A Fur box homolog is
nested within the predicted promoter sequence of hbpA and
has 53% identity to the E. coli Fur consensus (21). The hbpA
ORF is followed 37 bp downstream by a 6-bp inverted repeat
that may act as a rho-independent transcriptional terminator.
Computer analysis of the encoded HbpA protein predicts
that it has 272 amino acids, a molecular mass of 29,270 Da, and
a pI of approximately 9.5. The predicted protein also contains
an internal 18-amino-acid stretch that is identical to the N
terminus as determined from HbpA protein (Fig. 6). A pre-
dicted secretory signal cleavage site (67) was found between
residues 21 and 22; one residue upstream of the sequence that
was determined by Edman degradation (Fig. 6). Proteolytic
cleavage at the actual peptidase cleavage site would yield a
mature, secreted protein of 27,098 Da. Transmembrane com-
puter predictions (TMPred program; ISREC server) identified
three potential transmembrane helices in mature HbpA, en-
compassing amino acid residues 34 to 55, 74 to 101, and 218 to
236, that may serve to anchor HbpA to the outer membrane.
Finally, the predicted HbpA sequence has a C-terminal phe-
nylalanine, a characteristic of most integral outer membrane
proteins (57).
Further analysis of the predicted full-length HbpA protein
was done using BLAST 2.0. The highest-probability alignments
resulting from this search included the Pap31 phage-associated
membrane protein from B. henselae (10) with 58.4% identity,
followed by the OMP31 porin protein of Brucella melitensis
(66) with 31.7% identity. Alignments of these three protein
FIG. 4. Immunoelectron microscopy showing surface localization of HbpA.
Immunogold analysis and negative staining were done as previously described
(50), using anti-HbpA and intact bacteria. Bar, 0.5 mm.
FIG. 5. Anti-HbpA Fab fragments inhibit hemin binding by B. quintana. The
percent hemin uptake as a function of treatment volumes is shown. B. quintana
was pretreated with 0, 40, or 80 ml of PBS or anti-HbpA Fab (0.2 and 0.4 mg/ml,
respectively) and then assayed by a standard liquid hemin-binding assay. The
values are the average of three determinations 6 the SEM.
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sequences are shown in Fig. 7 and indicate several regions of
homology. Inspection of the genes encoding these two ho-
mologs reveal that, like hbpA, each gene contains a potential,
previously unrecognized Fur box in its respective promoter
sequence.
High-stringency Southern blots (7% DNA mismatch) showed
that the four other Bartonella species known to be human
pathogens (i.e., B. bacilliformis, B. clarridgeiae, B. elizabethae,
and B. henselae) possess hbpA homologs. Likewise, B. doshiae
DNA also produced a positive hybridization signal. However,
B. grahamii and B. vinsonii did not possess homologs when
analyzed at this level of stringency (data not shown).
Expression of hbpA in E. coli and characteristics of rHbpA.
E. coli XLOLR containing pHBP-CMV were found to synthe-
size recombinant HbpA (rHbpA) (Fig. 8). Although the pro-
tein was not apparent on Coomassie blue-stained gels (data
not shown), it was clearly detected on immunoblots (Fig. 8A).
The cloned hbpA gene is apparently expressed in E. coli from
its own promoter, as the gene is in opposite orientation to
the lac promoter in the pBK-CMV vector. E. coli XLOLR or
XLOLR containing the cloning vector pBK-CMV (Fig. 8A,
lanes 1 and 2, respectively) did not produce rHbpA.
Liquid hemin-binding assays using XLOLR, XLOLR(pBK-
CMV), or XLOLR(pHBP-CMV) did not reveal significant
differences in hemin binding, indicating that rHbpA does not
confer a hemin-binding phenotype upon E. coli (data not
shown). However, in vitro analyses with rHbpA clearly show
that it can bind hemin on blots (Fig. 8B, lane 1), as observed
with B. quintana HbpA (Fig. 1). Taken as a whole, these results
suggest that rHbpA, although capable of binding hemin, can-
not do so in E. coli, perhaps because of improper folding or
lack of surface exposure.
DISCUSSION
A number of bacterial pathogens have evolved systems for
accumulating hemin in order to satisfy their iron (43, 60),
protoporphyrin ring (15, 17), or cytochrome cofactor (40) re-
quirements. In addition, hemin has been shown to facilitate
entry of certain bacterial pathogens into their respective host
cells (20, 58). Early studies with B. quintana showed that the
pathogen has the highest in vitro hemin requirement for any
known bacterium: 20 to 40 mg/ml (41). The reasons for this
extraordinary need and the mechanism(s) whereby hemin is
acquired are unknown. The unusual strategy of erythrocyte
parasitism (hemotrophy) practiced by all Bartonella species
may have evolved to meet the bacterium’s tremendous need
for this molecule. Early studies with B. quintana indicated that
iron, and not the protoporphyrin ring, is the critical component
provided by hemin supplements (41). In either case the bacte-
rium would require the synthesis of a hemin receptor on the
outer surface to facilitate the acquisition of the iron needed for
growth.
We have identified and characterized a gene, hbpA, in B.
quintana that encodes a protein, designated HbpA, that re-
tained the ability to bind hemin after SDS-PAGE and electro-
phoretic transfer to nitrocellulose. Initial analyses suggested
HbpA was a membrane protein with an apparent molecular
mass of 30 kDa. Triton X-114 phase partitioning and heat
modification studies strongly suggested that the protein was an
integral membrane protein that localized to the outer envelope
of B. quintana. These results were confirmed by immunoblot,
comparing inner and outer membrane preparations probed
with polyclonal antibody to HbpA, and immunoelectron mi-
croscopy, which indicated that the protein was not only found
in the outer membrane but was also surface exposed. The
observed phenomenon of heat modification has been associ-
ated with numerous outer membrane proteins from other bac-
teria and may be a reflection of HbpA’s interaction with lipo-
polysaccharide (2), interaction with peptidoglycan (4, 49), or
tertiary structure (25). Interestingly, the increase in the appar-
ent molecular mass of HbpA when heated (heated 30 kDa
versus unheated 25 kDa) is the opposite of what has been
observed in Porphyromonas gingivalis, where the reported
HBPs decrease their apparent molecular masses from 30 to 24
kDa (29) and from 32 to 19 kDa (11) when heated.
Fab fragments purified from a polyclonal antibody specific
for HbpA were able to significantly decrease the amount of
hemin bound by B. quintana in a dose-dependent manner.
With Fab concentrations of 0.2 and 0.4 mg/ml we observed
average decreases of 26 and 41%, respectively, in the amount
of hemin bound relative to controls. These results suggest that
HbpA plays a role in the ability of the organism to acquire
hemin from its surroundings and that antibody to HbpA may
inhibit that interaction. The inhibition of hemin binding by
antibodies specific for HbpA was similar to what has been
FIG. 6. Sequence of hbpA, its encoded protein, and identification of a po-
tential Fur box in the promoter region. Nucleotides within the hbpA ORF are
given in uppercase letters. The promoter, as determined by prokaryotic promoter
prediction by neural network, is shown in boldface lowercase letters, with a
potential transcriptional start site (TSS) indicated by a boldface uppercase “G.”
The fur box homolog within the promoter region is boxed. A potential ribosome-
binding site (RBS) is indicated above the sequence. The deduced amino acid
sequence of HbpA is shown below the second base of its respective triplet codon.
Amino acids constituting the secretory signal sequence are shown in boldface.
The N-terminal sequence experimentally determined from mature HbpA is
boxed. The stop codon is denoted by an asterisk. Inverted repeats constituting a
potential r-independent terminator of transcription are indicated by opposing
arrows.
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demonstrated with other bacterial pathogens, where antibod-
ies to components of the iron scavenging mechanism were
shown to inhibit ligand-receptor interactions in vitro (24, 68).
Hemin binding was not fully abolished in the presence of
anti-HbpA Fab fragments, implying that B. quintana has mul-
tiple receptors that bind hemin, as is the case for P. gingivalis
(52, 62) and Haemophilus influenzae (26, 48). This possibility is
supported by the hemin blot (Fig. 1), which demonstrates that
HbpA is only one of eight membrane-associated proteins in B.
quintana that has an affinity for hemin. The exact localization
of the additional hemin-binding membrane proteins and their
involvement in iron acquisition are currently under investiga-
tion.
Partially purified HbpA was subjected to N-terminal se-
quence analysis, where we were able to reproducibly determine
the first 18 amino acids of the mature protein. A BLASTp
search of the NCBI database indicated a close match (63%
identity) to the N terminus of a phage-associated protein
(Pap31) identified in B. henselae (10). Pap31 was previously
reported to be a membrane protein of B. henselae that copu-
rifies with bacteriophage during phage isolation and purifica-
tion (3). Due to the similarity between the N terminus of
mature Pap31 and HbpA, the deduced nucleotide sequence of
pap31 was utilized as a template to develop primers in order to
PCR amplify hbpA from B. quintana. A PCR amplicon was
obtained, cloned, and used to probe a B. quintana genomic
library, where the full-length gene and accompanying flanking
sequences were cloned and analyzed.
Southern analysis showed that all pathogenic Bartonella spp.
harbor hbpA homologs, implying a correlation between the
presence of hbpA and pathogenicity. It was also evident that
HbpA is synthesized as a preprotein with a 22-amino-acid
signal sequence and a signal peptidase cleavage site. The
HbpA signal sequence was strikingly similar (.90% identity,
100% similarity) to the signal sequence of Pap31 (10), suggest-
ing that Pap31 may also localize to the outer membrane in B.
henselae.
A BLASTp search of the NCBI database using the full-
length HbpA indicated that it was related not only to Pap31 of
B. henselae but also to Omp31 of Brucella melitensis, which
encodes for a 31- to 34-kDa outer surface protein proposed to
be a porin (66). Interestingly, neither Pap31 nor Omp31 have
been implicated in hemin binding or iron acquisition. Yet,
within the putative promoter regions of hbpA, pap31, and
omp31 we identified an imperfect palindrome overlapping
their putative 210 regions that closely resembles the ferric
uptake regulator (Fur) consensus sequence found in E. coli
(21). Similar Fur consensus sequences in Yersinia (55), Neisse-
ria (36), and Shigella (38) spp. have been observed upstream of
genes that encode proteins that are involved in, or associated
with, iron acquisition. Due to the presence of a Fur consensus
sequence (53% identity to the E. coli Fur consensus) and the
recent identification of fur homologs in B. bacilliformis and B.
henselae (L. Hendrix, Abstr. 15th Sesquiannu. Meet. Am. Soc.
Rickettsiol. abstr. 10, 2000), hbpA (as well as pap31 and
omp31) may be regulated by Fur in response to fluctuating
cellular iron levels. We have yet to demonstrate any regulation
FIG. 7. Multiple sequence alignment of B. quintana HbpA with B. henselae Pap31 and B. melitensis Omp31. Identical amino acid residues are noted in black,
conserved residues in gray and introduced gaps by hyphens. The GenBank accession numbers for the Pap31 and Omp31 homologs are AF001274 and U39453,
respectively.
FIG. 8. Expression of hbpA in E. coli and ability of recombinant HbpA to
bind hemin in vitro. (A) Immunoblot developed with anti-HbpA antibody, show-
ing lysates of E. coli XLOLR containing no plasmid (lane 1), pBK-CMV cloning
vector (lane 2), or pHBP-CMV (lane 3). (B) Blots of an E. coli XLOLR(pHBP-
CMV) lysate probed with hemin showing rHbpA binding hemin (indicated by an
asterisk) (lane 1). The corresponding immunoblot developed with anti-HbpA
antiserum and ECL reagents (Amersham), identifying the recombinant HbpA
(arrowed) (lane 2), is also shown. All samples were solubilized at 100°C in LSB.
Molecular mass standards are given to the left in kilodaltons.
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of hbpA as a result of hemin or iron availability in vitro, but the
abundance of HbpA on the cell surface of B. quintana grown
on blood agar would suggest that cells grown under typical
plating conditions (presumably iron replete) express hbpA.
The similarities between pap31 and hbpA suggest that they
are homologs, and this brings into question the function of
Pap31 in B. henselae. While this study does not directly address
this question, we propose that both Pap31 of B. henselae and
Omp31 of B. melitensis are involved in iron acquisition. Pap31’s
original designation as a phage-associated membrane protein
in B. henselae (3, 10) could be explained by the hypothesis that
the bacteriophage may use Pap31 as a receptor on the outer
surface of the bacterium. Thus, the receptor (presumably
Pap31) may copurify with the phage.
Recombinant HbpA did not confer a hemin-binding pheno-
type to E. coli but instead retained the ability to bind hemin
after SDS-PAGE and electrophoretic transfer to blots. This
observation suggests that rHbpA is either improperly folded or
not localized to the outer surface in E. coli. The signal se-
quence preceding HbpA may not be recognized or properly
translocated by the secretory machinery of E. coli. Similar
results were reported for the cloning and expression of B.
melitensis omp31, where recombinant Omp31 was not surface
exposed but still maintained the ability to form SDS-resistant
oligomers (characteristic of bacterial porins) in E. coli (66).
HbpA is the first potential virulence determinant character-
ized from B. quintana. This pathogen’s high in vitro require-
ment for hemin makes it an ideal model to study iron acqui-
sition and hemin binding in this genus. Obtaining iron needed
for growth from hemin is typically a TonB-dependent process
that entails the synthesis of a surface receptor to facilitate the
binding of the ligand, a protein in the periplasmic space to
ferry the hemin to the cytoplasmic membrane, and finally a
permease to bring the molecule into the bacterial cell (35). We
have cloned and characterized the first component, a gene
encoding an HBP, in this choreographed chain of events. The
remaining components must be identified and characterized in
order to fully understand the role that hemin binding plays in
the pathogenesis of Bartonella.
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